Nationwide registry for autoimmune liver diseases in Canada
Canadian Network for Autoimmune Liver Disease
This study is creating a detailed registry of people in Canada with autoimmune liver diseases like Primary Biliary Cholangitis and Autoimmune Hepatitis to better understand how these conditions progress over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 15 sites (Calgary, Alberta and 14 other locations) |
| Trial ID | NCT03569826 on ClinicalTrials.gov |
What this trial studies
The Canadian Network for Autoimmune Liver Disease (CaNAL) is a longitudinal observational cohort study that aims to create a comprehensive registry of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH), or overlap syndrome. By collecting and analyzing patient data from major Canadian medical centers, the study seeks to enhance understanding of these rare and progressive liver diseases. The focus is on high-quality long-term follow-up, which will provide valuable insights into patient characteristics and disease progression over time.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with Primary Biliary Cholangitis or Autoimmune Hepatitis.
Not a fit: Patients under 18 years of age will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients with autoimmune liver diseases.
How similar studies have performed: Other studies focusing on registry-based approaches for rare diseases have shown success in improving patient outcomes and understanding disease mechanisms.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Primary Biliary Cholangitis and/or Autoimmune Hepatitis Exclusion Criteria: * Less than 18 years of age
Where this trial is running
Calgary, Alberta and 14 other locations
- Foothills Medical Centre — Calgary, Alberta, Canada (Not_yet_recruiting)
- University of Alberta Hospital — Edmonton, Alberta, Canada (Recruiting)
- Vancouver General Hospital — Vancouver, British Columbia, Canada (Not_yet_recruiting)
- St. Paul's Hospital — Vancouver, British Columbia, Canada (Not_yet_recruiting)
- Health Sciences Centre — Winnipeg, Manitoba, Canada (Not_yet_recruiting)
- Queen Elizabeth II Health Sciences Centre — Halifax, Nova Scotia, Canada (Active_not_recruiting)
- McMaster University Medical Centre — Hamilton, Ontario, Canada (Not_yet_recruiting)
- Kingston Health Sciences Centre (HDH Site) — Kingston, Ontario, Canada (Active_not_recruiting)
- London Health Sciences Centre - University Hospital — London, Ontario, Canada (Recruiting)
- The Ottawa Hospital — Ottawa, Ontario, Canada (Recruiting)
- Toronto General Hospital — Toronto, Ontario, Canada (Recruiting)
- Centre hospitalier de l'Université de Montréal — Montreal, Quebec, Canada (Recruiting)
- McMaster University Medical Centre — Montreal, Quebec, Canada (Not_yet_recruiting)
- Université de Sherbrooke — Sherbrooke, Quebec, Canada (Recruiting)
- Royal University Hospital — Saskatoon, Saskatchewan, Canada (Recruiting)
Study contacts
- Principal investigator: Bettina Hansen, PhD — University Health Network, Toronto General Hospital
- Study coordinator: Surain Roberts, AB
- Email: surain.roberts@uhn.ca
- Phone: 613 291 5039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.